Decisions of the Ministry of Health of the Czech Republic have a major impact on decision-making practice in the area of pricing and reimbursement of medicines. Knowledge of the individual proceedings and the impact on future decisions is almost a necessity for marketing authorisation holders. Pharmeca a.s. therefore now offers an interactive overview of the decisions of the Ministry of Health of the Czech Republic with more detailed information on each procedure.